Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7912
-0.0062 (-0.78%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7820
-0.0092 (-1.16%)
After-hours: Mar 16, 2026, 7:39 PM EDT
Evogene Revenue
In the year 2025, Evogene had annual revenue of $3.85M, down -54.73%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025, a decrease of -79.65%.
Revenue (ttm)
$3.95M
Revenue Growth
-51.39%
P/S Ratio
1.79
Revenue / Employee
$32,932
Employees
117
Market Cap
6.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.85M | -4.66M | -54.73% |
| Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
| Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
| Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
| Dec 31, 2018 | 1.75M | -1.63M | -48.33% |
| Dec 31, 2017 | 3.38M | -3.16M | -48.30% |
| Dec 31, 2016 | 6.54M | -4.59M | -41.23% |
| Dec 31, 2015 | 11.13M | -3.38M | -23.31% |
| Dec 31, 2014 | 14.51M | -3.07M | -17.46% |
| Dec 31, 2013 | 17.58M | 509.00K | 2.98% |
| Dec 31, 2012 | 17.07M | 2.17M | 14.57% |
| Dec 31, 2011 | 14.90M | 2.34M | 18.61% |
| Dec 31, 2010 | 12.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moolec Science | 7.83M |
| Bolt Biotherapeutics | 7.70M |
| Xenetic Biosciences | 2.98M |
| CollPlant Biotechnologies | 2.48M |
| SciSparc | 1.31M |
| Alaunos Therapeutics | 6.00K |
EVGN News
- 3 days ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 3 days ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 11 days ago - Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 11 days ago - Evogene Earnings Review: Q4 Summary - Benzinga
- 11 days ago - Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 12 days ago - An Overview of Evogene's Earnings - Benzinga